Skip to content

Corvel CRVL Net additions (releases) charged to costs and expenses

Net additions (releases) charged to costs and expenses at other companies

SS&C Technologies logo
SS&C TechnologiesSSNC
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$248.5M+7.4%
Gross profit$63.0M+8.3%
Net income$31.0M+17.4%
EPS (diluted)$0.61+19.6%

Balance sheet

See full
Cash & equivalents$233.1M+36.6%
Total debt$28.1M+0.1%
Total equity$394.2M+22.4%
Total assets$643.0M+17.8%

Cash flow

See full
Operating cash flow$29.5M+28.6%
CapEx$9.2M+5.9%
Free cash flow$20.3M+42.3%

Valuation

See full
Market cap$3.03B-51.4%
Enterprise value$2.82B-53.8%
P/E27.4×-38.0×
P/S3.2×-3.8×

Profitability

See full
Gross margin24.3%+0.9pp
Net margin11.5%+0.9pp
FCF margin11.5%+1.3pp

Returns & leverage

See full
Return on equity30.8%-2.6pp
Debt / equity0.1×0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Corvel’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Corvel's net additions (releases) charged to costs and expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corvel's net additions (releases) charged to costs and expenses?
Corvel (CRVL) reported net additions (releases) charged to costs and expenses of $382K in Q3 2025.
How has Corvel's net additions (releases) charged to costs and expenses changed year-over-year?
Corvel's net additions (releases) charged to costs and expenses decreased by 13.0% year-over-year, from $439K to $382K.